Trials / Completed
CompletedNCT04417569
A Proof of Concept Study of Serum Progesterone Levels for IVF/ICSI Following HCG Trigger for Oocyte Maturation
A Proof of Concept Study to Determine the Rise of Progesterone Levels After Human Chorionic Gonadotrophin (hCG) Trigger in Stimulated Cycles of IVF/ICSI
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- ART Fertility Clinics LLC · Academic / Other
- Sex
- Female
- Age
- 18 Years – 42 Years
- Healthy volunteers
- Accepted
Summary
This study will determine the rise of progesterone levels after human chorionic gonadotrophin (hCG) trigger in stimulated cycles IVF/ICSI
Detailed description
Studies have suggested that controlled ovarian hyperstimulation adversely affects endometrial receptivity. In ovarian stimulation cycles with exogenous gonadotrophins there is an ongoing debate regarding the effect of a late follicular phase progesterone level on reproductive outcomes. It is not yet clarified if an elevated serum progesterone level in the late follicular phase is a symptom or cause of an adverse effect on reproductive outcomes. A new hypothesis is evolving and gaining momentum providing a novel explanation for the association between late follicular phase progesterone rise and reproductive outcome. It is proposed that exogenous FSH (Follicle-stimulating hormone) administration results in supraphysiological levels of FSH, which induce an abundance of LH (luteinizing hormone) receptors on granulosa cells causing the follicles to become hypersensitive to LH-like activity (ie hCG trigger). Based on this hypothesis, the focus should be placed on the hCG trigger rather than on the late follicular phase progesterone rise.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | hCG | human chorionic gonadotropin |
| DIAGNOSTIC_TEST | Ultrasound | Endometrial thickness monitoring |
| OTHER | Blood test | Progesterone, Luteinizing Hormone, Estradiol |
Timeline
- Start date
- 2021-02-04
- Primary completion
- 2021-05-26
- Completion
- 2021-06-30
- First posted
- 2020-06-04
- Last updated
- 2022-02-18
Locations
1 site across 1 country: United Arab Emirates
Source: ClinicalTrials.gov record NCT04417569. Inclusion in this directory is not an endorsement.